Abstract
End-stage ankle arthritis causes significant pain, disability, and reduction in the quality of life. The common causes of ankle arthritis are post-traumatic (70%), secondary to rheumatoid arthritis (12%), and idiopathic (7%). Surgical arthrodesis of the tibiotalar joint is used to help alleviate the symptoms and signs of end-stage ankle arthritis. The first documented description of ankle arthrodesis is by Albert of Vienna in 1879 who reported curettage of the articular cartilage to enable fusion of the ankle joint. Since that time, this process has been refined significantly culminating in the introduction of arthroscopic ankle arthrodesis (AAA) by Schneider in 1983. AAA is now considered as the current gold standard to help achieve effective and predictable pain relief and improved function for patients who suffer with end-stage ankle arthritis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Arthroscopic Surgery and Sports Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
